Stanford, California 94305


Purpose:

The goal of this study is to study NIS expression in benign and malignant breast and thyroid samples using archival formalin-fixed paraffin-embedded tissue sections.


Study summary:

The objective of the study is to further understanding of proteins that occur in both normal cells and tumor cells and to learn more about certain diseases and potential alternative treatments for these diseases.


Criteria:

Inclusion Criteria: 1. Patient must be over the age of 18. 2. Patients must have benign and malignant breast and thyroid cancer. 3. Patient mus sign consent form. Exclusion Criteria: 1. No children will be allowed.


NCT ID:

NCT00568438


Primary Contact:

Principal Investigator
Irene L. Wapnir
Stanford University


Backup Contact:

N/A


Location Contact:

Stanford, California 94305
United States

Irene Wapnir
Phone: 650-736-1353
Email: irene.wapnir@stanford.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: August 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.